九典制药：受让成都佩德生物医药有限公司拥有的JIJ02凝胶全部已开发成果及相应知识产权

Core Viewpoint - JiuDian Pharmaceutical has acquired the developed results and corresponding intellectual property of JIJ02 gel from Chengdu Ped Bio-Pharmaceutical Co., Ltd. for 90 million yuan to enrich its product line [2] Summary by Category Company Developments - JiuDian Pharmaceutical announced the acquisition of JIJ02 gel, previously known as "PD-DP-008 gel," to enhance its product offerings [2] Financial Performance - For the year 2024, JiuDian Pharmaceutical's revenue composition is as follows: - Pharmaceutical preparations: 80.43% - Active pharmaceutical ingredients: 7.81% - Pharmaceutical excipients: 6.69% - Plant extracts and others: 3.73% - Technology transfer and services: 1.29% [2]